Article Information
History
- February 11, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- John J. L. Jacobs1,*,
- Inés Beekers1,
- Inge Verkouter1,
- Levi B. Richards1,
- Alexandra Vegelien1,2,
- Lizan D. Bloemsma3,
- Vera A. M. C. Bongaerts4,
- Jacqueline Cloos5,
- Frederik Erkens6,
- Patrycja Gradowska7,
- Simon Hort6,
- Michael Hudecek8,
- Manel Juan9,10,11,
- Anke H. Maitland-van der Zee3,
- Sergio Navarro Velázquez9,10,
- Lok Lam Ngai5,
- Qasim A Rafiq12,
- Carmen Sanges8,
- Jesse Tettero5,
- Hendrikus J. A. van Os13,
- Rimke C. Vos14,
- Yolanda de Wit5 and
- Steven van Dijk1
- 1Clinical Care & Research, ORTEC B.V., Zoetermeer, The Netherlands
- 2Faculty of Mathematics, VU, Amsterdam, The Netherlands
- 3Department of Pulmonary Medicine, Amsterdam UMC, The Netherlands
- 4Department of Public Health and Primary Care, LUMC, Leiden, The Netherlands
- 5Department of Haematology, Amsterdam UMC, The Netherlands
- 6Fraunhofer IPT, Aachen, Germany
- 7Dutch-Belgian Hemato-Oncology Cooperative Group Data Center–Erasmus MC Cancer Institute, Rotterdam, The Netherlands
- 8University Clinic Würzburg, Germany
- 9Foundation for Biomedical Research, Barcelona, Spain
- 10Immunology department, Hospital Clinic of Barcelona, Barcelona, Spain
- 11HSJD-Clinic Immunotherapy platform, Barcelona, Spain
- 12Advanced Centre for Biochemical Engineering, University College London, UK
- 13National eHealth Living Lab, LUMC, Leiden, The Netherlands
- 14Public Health & Primary Care, Leiden University Medical Center
- ↵*Corresponding author. John.Jacobs{at}ortec.com
Posted February 11, 2024.
